. . . . . . . . . "Among TCAs, doxepin (sinequan) appears to be best suited for managing insomnia in healthy adults. Doxepin works as a selective antagonist to H(1) receptors, which promote the initiation and maintenance of sleep (Owen, 2009) (Table 2). Ultra-low doses of this drug (< 6 mg per day) significantly improve and sustain both maintenance and duration of sleep (Rojas-Fernandez and Chen, 2014; Weber et al., 2010). Another frequently prescribed TCA is amitriptyline, which as a long-term option is found to be effective for patients with ongoing sleep problems (Everitt et al., 2014; Pagel and Parnes, 2001)." . . . . . . "Adults" . . "2021-08-16T20:58:17.568355"^^ . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB" . "VR1yH82Et+x4EPbQvlsuWp+1sr0IOLWadZ06/kZvcVqrmfG82mmXRktRBFXok8imVUpV7/k2oeUVIaiaC5N4Vy+H7BrPNyKfnkMNseMcn/W2EGNWoV7c61tVnvibyvr9Qhw94IZ1wQRXtujOPy9w6KJEJTLZoXn2efwfJdTZDXA=" . . "2021-08-16T20:58:17.568355"^^ . . .